Merck & Company, Inc. (
) will begin trading ex-dividend on March 13, 2014. A cash dividend
payment of $0.44 per share is scheduled to be paid on April 07,
2014. Shareholders who purchased MRK stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
2.33% increase over the same period a year ago.
The previous trading day's last sale of MRK was $56.69,
representing a -1.67% decrease from the 52 week high of $57.65 and
a 30.29% increase over the 52 week low of $43.51.
MRK is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). MRK's current earnings per share, an indicator of a company's
profitability, is $1.46. Zacks Investment Research reports MRK's
forecasted earnings growth in 2014 as -.72%, compared to an
industry average of -.6%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to MRK through an Exchange
Traded Fund [ETF]?
The following ETF(s) have MRK as a top-10 holding:
- iShares U.S. Pharmaceutical ETF (
- First Trust Morningstar Dividend Leaders Index Fund (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Vanguard Health Care ETF (
The top-performing ETF of this group is IHE with an increase of
23.85% over the last 100 days. It also has the highest percent
weighting of MRK at 9.1%.